April 14-15, 2026 | Hyatt Regency San Francisco Airport
USDM Life Sciences is proud to return to the 2026 American Biomanufacturing Summit, where over 200 biopharma and biotech leaders gather to explore the emerging trends, operational challenges, and technological innovations shaping the future of biotechnology. Make sure to take advantage of our discount code and attend our workshop!
As manufacturing complexity increases and regulatory expectations evolve, biomanufacturers must modernize operations without compromising compliance, governance, or quality. At this year’s summit, USDM will demonstrate how Agentic AI and intelligent automation are enabling the next generation of compliant, resilient, and high-performing manufacturing environments.
The Next Era of Biomanufacturing Is Intelligent
Biomanufacturers today face mounting pressures:
- Increasing regulatory scrutiny
- Rising production complexity across global sites
- Data silos between MES, ERP, QMS, and supply chain systems
- Workforce constraints and operational bottlenecks
- Downtime that directly impacts patient supply and revenue
The question is no longer whether to adopt AI. The question is:
How do you implement AI responsibly in regulated manufacturing — while strengthening compliance and operational control? USDM helps life sciences organizations operationalize AI within GxP environments to achieve measurable, transformative outcomes — improving efficiency, minimizing deviations, and maintaining continuous audit-readiness.
If you still need to register, use our VIP code for a discounted pass: USDMVIP!
Workshop/Presentation | Day 1 | Apr 14 | 12:05 PM | Room 4
INTELLIGENT QUALITY MANAGEMENT: ARCHITECTING AI-DRIVEN OVERSIGHT IN MODERN BIOMANUFACTURING
- Transitioning from static, manual quality workflows to AI-enabled, continuously learning systems embedded across GMP operations
- Deploying agentic and autonomous AI to monitor risk, interpret complex quality signals, and orchestrate cross-functional workflows in real time
- Accelerating deviation resolution, batch review, and inspection readiness while improving transparency, consistency, and operational scalability
- Establishing governance, validation, and control frameworks to deploy AI responsibly within regulated environments and strengthen compliance resilience
Speaker
Hovsep Kirikian
Vice President, Strategy & Operations, USDM Life Sciences
Hovsep Kirikian is a strategic operations leader with over two decades of life sciences expertise. As VP of Strategy and Operations at USDM, Hovsep drives organizational alignment and leads USDM’s Veeva services practice. With a foundation in regulatory science and biology, he enables companies to scale digital quality and clinical operations while maintaining audit readiness. His work is centered on delivering measurable outcomes across compliance, efficiency, and innovation.
Meet the USDM Team Onsite
Connect with our executive leaders to discuss your manufacturing modernization roadmap:
- Hovsep Kirikian, VP Strategy & Operations
- Jim Murray, Chief Technology Officer
- Justin Ott, VP Business Development
- Josh Ertmer, Client Services Director
- Lisa Om, VP Marketing
The future of biomanufacturing will be defined by organizations that can:
- Reduce downtime through predictive intelligence
- Optimize workflows across integrated systems
- Strengthen data integrity and governance
- Maintain continuous audit-readiness
- Empower teams with AI-enabled decision support
USDM Life Sciences partners with biotech and biopharma manufacturers to build resilient, intelligent operations that accelerate innovation while protecting compliance.
Fill out the form to schedule a meeting with our SMEs that will be on-site in San Francisco. >>>
We look forward to seeing you there!